Alacris Theranostics GmbH is a Berlin based company with the mission to exploit Next Generation Sequencing and other omics data through its predictive modelling system ModCellTM, for drug development and personalised medicine in oncology. This approach was originally developed at the Max Planck Institute for Molecular Genetics in Berlin and is exclusively licensed to Alacris.
Alacris was founded in 2008 as a spin-off company of the Max Planck Institute for Molecular Genetics by Hans Lehrach, one of Germany’s leading molecular biologists and entrepreneurs, together with pharmaceutical industry executives and researchers from Harvard Medical School and Charité – Universitätsmedizin Berlin.
If you want to work in an international environment at the forefront of science and be part of the fight against cancer, contact us.
We are looking for qualified and highly committed colleagues who will help to shape our company and the future of personalised medicine. We look forward to receiving your application, including a CV, detailed professional profile and the names and contact details of at least two referees who are familiar with your work.
Currently we invite applications for
Please send your application as single PDF file by email to: email@example.com